The free virtual summit & job fair runs from June 25-28 as part of PowerToFly's Diversity Reboot series NEW YORK, June 14, 2024 /PRNewswire/ -- Acclaimed actor & author Alan Cumming, currently the...

Leading manufacturer of light tactical vehicles and mobility systems, AM General, will feature the next generation Joint Light Tactical Vehicle A2 (JLTV A2) for the first time outside of the...

From clearing snow, mowing the lawn or blowing leaves - Yarbo makes year-round yard and garden maintenance child's play Yarbo is the most innovative and versatile yard robot on the market. It can...

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced...

"The Contrarian's Compass: Navigating Emerging Tech Hype" to run on the Innovation Track at Cannes NEW YORK, June 14, 2024 /PRNewswire/ -- Stagwell (NASDAQ: STGW), the challenger network built to...

The Water Environment Federation's second annual Circular Water Economy Summit (CWES) will take place in Dallas, Texas, July 15-17. This unique event gathers industrial and municipal water experts...

The Learning Guild, a CloserStill Media business, shared program details today for the 20th Anniversary of DevLearn, North America's largest learning technology event. More than 4,000 learning...

24-month overall survival rate of 67 percent achieved with TALVEY® 0.8 mg/kg biweekly dosing in the Phase 1/2 MonumenTAL-1 study MADRID, June 14, 2024 /PRNewswire/ -- Johnson & Johnson (NYSE:...

- Data continue to support revumenib's potential to enhance current standard of care agents - - 96% CRc (23 of 24 pts) observed in BEAT AML trial exploring revumenib in combination with...

- Oral presentation highlighting final five-year efficacy data from the registrational Phase 2 trial of REZLIDHIA® (olutasidenib) in heavily pretreated patients with R/R mIDH1 AML, including...